Allied Market Research
Loading...
0
New
New
2022
Meningitis Imaging Market

Meningitis Imaging Market by Product Type (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Positron Emission Tomography (PET), Disease Type (Bacterial Meningitis, Viral Meningitis, Fungal Meningitis and Others), and End User (Hospitals & Clinic, and Diagnostic Centers): Global Opportunity Analysis and Industry Forecast, 2021––2030

A15000
Pages: 238
Dec 2021 | 418 Views
   
Author(s) : Divyani Talekar, Shilpi Chowdhury , Onkar Sumant
Tables: 101
Charts: 43
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Meningitis Imaging Market

Request Now !

Global meningitis imaging market was valued at $164.70 thousand in 2020, and is projected to reach $243.72 thousand by 2030, registering a CAGR of 4.0% from 2021 to 2030. meningitis is an inflammation caused to brain and spinal cord.

It caused swelling of the brain which triggers the symptoms such as fever, headache and stiff neck. Meningitis includes some types such as bacterial meningitis, viral meningitis, fungal meningitis and others. In case of bacterial meningitis bacteria enter the blood stream and travel to the brain and cause bacterial meningitis. Ear and sinus infection is one of the major reason to get infected by bacterial meningitis. It includes bacteria such as streptococcus pneumonia, neisseria meningitides, and haemophilus influenza. Viral meningitis is usually shows mild symptoms. It includes the viruses like HIV mumps, herpes simplex virus and west nile virus. Fungal meningitis is also cause by person to person. It is life threatening if it is treated by at the right time.

Market Infographics_Global-Meningitis-Imaging-Market

Get more information on this report : Request Sample Pages

Computed tomography is a major tool to detect the infection of meningitis. It is computerized x-ray imaging procedure in which it create detailed images of internal organs, soft tissue and blood vessels. In this procedure the cross-sectional images generated during computed tomography scan. Computer tomography scanning is the best method for detecting many different types of meningitis and the images allow doctors to identify the presence of infection associated with brain and spinal cord. It is also used to visualize the infection and evaluate injuries related to head, spine, heart, abdomen, and chest. It can diagnose a life threatening conditions. Whereas, magnetic resonance imaging (MRI) is also an effective imaging system. In addition, this diagnostic tools collectively known as neuroimaging. This neuroimaging can identify the situation that may predispose to bacterial meningitis. It is also used to monitor complications of meningitis such as empyema, hydrocephalus, and parenchymal abscess. 

Growth of the global meningitis imaging market is majorly driven by increase in prevalence of meningitis disease; increase in various types of meningitis such bacterial meningitis, viral meningitis and fungal meningitis; increase in cases of tuberculosis which cause bacterial meningitis; rise in demand for magnetic resonance imaging , positron emission tomography and computed tomography scan to detect the infection; surge in usage of computed tomography scans to determine the efficacy of treatment; increase in development of new imaging system by large number of key players; and advancements in technologies in the field of  imaging system.

According to Egyptian Journal of Radiology and Nuclear Medicine the value of contrast enhanced FLAIR magnetic resonance imaging (MRI) for detecting meningitis disease is an effective management and more reliable. It should be considered as the first line imaging modality in brain infections.

Magnetic resonance imaging is superior test in detecting extra-axial fluid collections due to lack of skull bony artifacts. Thus, rise in burden of meningitis, the demand for magnetic resonance imaging scan to diagnosis, anticipated the growth of the meningitis imaging market. Furthermore, rise in geriatric population, surge in demand to identify efficacy of the treatment, these factors fuel the growth of the meningitis imaging market. For instance, in December 2020, United Imaging launched uCT ATLAS an ultra-wide bore computed tomography system with innovative artificial intelligence technology designed to control pandemic. Thus, increase in awareness among people the use of computed tomography imaging for meningitis fuels the market growth. In March 2021, Nikon Corporation launched a new 225 kV, micro-focus X-ray CT system. This provides both interior and exterior sample to be calculated and examined non-destructively.

In addition, increase in number of manufacturers of imaging system, anticipate the growth of the market. For instance, in December 2020, Waygate Technologies ,a Baker Hughes business the world leader has launched its first high-energy computed tomography (CT) system, the Phoenix Power scan HE. Furthermore, rise in awareness among individuals for early diagnosis and management of meningitis, increase in number of products approvals is expected to provide remunerative opportunities for the expansion of the global meningitis imaging market during the forecast period.

The COVID-19 outbreak is anticipated to have a positive impact to fuel the growth of the global meningitis imaging market. At the starting of July 2020, a few cases have reported as an infection of meningitis with covid-19 at the same time. In that case computer tomography and magnetic resonance imaging are the most effective tools being used to identify the infection and to monitor the efficacy of the treatment. Implementing appropriate preventative safety measures, optimizing chest CT protocols, and developing a consistent reporting system based on pulmonary findings in this condition had improved the clinical value of CT. Thus rise in number of Covid-19 cases rise the usage of computed tomography scan is anticipated to drive the meningitis imaging market in the forecast period.

Thus, technological advancements in diagnostic instrument and rise in awareness regarding early diagnosis propel the growth of the market. However, high cost associated with imaging systems installation and maintenance is expected to restrict the market growth during the forecast period.

Meningitis Imaging Market Segmentation

The global meningitis imaging market is segmented into product type, disease type, end user and region. By product type, the market is categorized into magnetic resonance imaging, computed tomography and positron emission tomography. 

On the basis of disease type, it is divided into bacterial meningitis, viral meningitis, fungal meningitis, and others. Depending on end user, it is categorized into hospitals & Clinic, and diagnostic centers. 

Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Latin America and Middle East & Africa).

Segment Review

Depending on product type, the computed tomography segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in R&D activities in the pharmaceutical & medical device industry, rise in demand for early detection, and surge in adoption of computed tomography systems. However, the magnetic resonance imaging segment is expected to witness considerable growth during the forecast period, owing to increase in number of diagnostic centers and increase in number of key players for development of computed tomography systems in the medical device industry.

Meningitis Imaging Market
By Product Type

Your browser does not support the canvas element.

Computed Tomography segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

By disease type, the viral meningitis segment was the major contributor in 2020, and is expected to maintain its lead during the forecast period, owing to increase in prevalence of meningitis, rise in consumption of contaminated food and increasing demand for early diagnostic. However, the bacterial meningitis segment is expected to witness considerable growth during the forecast period, due to increase in number of covid-19 cases cause meningitis, rise in demand for early diagnosis, and development of advanced computed tomography and magnetic resonance imaging  systems in the hospital and clinics.

On the basis of end user, the hospitals & clinic segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to large number key players offering advanced magnetic resonance imaging, positron emission tomography and computed tomography devices, increase in demand to determine efficacy of treatments, development of novel & innovative imaging systems and advancement in R&D activities for diagnosis of various diseases. However, the diagnostic centers segment is expected to witness considerable growth during the forecast period, owing to increase in use the detection of cerebrovascular diseases which can lead can lead to stroke, or even death, surge in awareness about CT and MRI scan.

Meningitis Imaging Market
By End User

Your browser does not support the canvas element.

Hospitals & Clinics segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

North America garnered the major share in the meningitis imaging market in 2020, and is expected to continue to dominate during the forecast period, owing to rise in prevalence of inflammatory diseases, presence of key players, development of the healthcare sector, presence of new innovative imaging systems, and advancement in technology for computed tomography in the region. However, Asia-Pacific is expected to register the highest CAGR of 4.2% from 2021 to 2030, owing to increase in prevalence of meningitis, rise in demand for early diagnosis, development of healthcare infrastructure.

The key players operating in the global meningitis imaging market include Accuray Incorporated, Canon Medical Systems Corporation, Fujifim Holdings Corporation, GE Healthcare, Koninklijke Philips N.V, Neusoft Medical Systems, Positron Corporation, Samsung Electronics Co.Ltd., Shimadzu Corporation, and Siemens AG.

Meningitis Imaging Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 4.2% during the forecast period.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the meningitis imaging market, and the current trends & future estimations to elucidate imminent investment pockets.
  • It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Key Market Segments

  • By Product Type
    • Magnetic Resonance Imaging (MRI)
    • Computer Tomography (CT)
    • Positron Emission Tomography
  • By Disease Type
    • Bacterial Meningitis
    • Viral Meningitis
    • Fungal Meningitis
    • Others
  • By End User
    • Hospitals & Clinics
    • Diagnostic Centers
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • Australia
      • India
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Latin America
      • Middle East & Africa
  • KEY MARKET PLAYERS
    • Accuray Incorporated
    • Canon Medical Systems Corporation
    • Fujifim Holdings Corporation
    • GE Healthcare
    • Koninklijke Philips N.V
    • Neusoft Medical Systems
    • Positron Corporation
    • Samsung Electronics Co.Ltd.
    • Shimadzu Corporation
    • Siemens AG
 

CHAPTER 1:INTRODUCTION

1.1.Report description
Key benefits for stakeholders
1.2.Key market segments

1.2.1.List of key players profile in the report

1.3.Research methodology

1.3.1.Secondary research
1.3.2.Primary research
1.3.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Escalating demand for healthcare services from an aging population
3.5.1.2.Rise in prevalence of  meningitis disease
3.5.1.3.Greater consumer awareness  and demand for preventive diagnostic screening
3.5.1.4.Utilization of artificial intelligence and augmented reality
3.5.1.5.Technological advancements in meningitis imaging systems

3.5.2.Restraint

3.5.2.1.High cost of installation and maintenance
3.5.2.2.Lack of adequate reimbursement and stringent regulatory framework

3.5.3.Opportunity

3.5.3.1.Growth opportunities in emerging markets

3.5.4.Impact analysis

3.6.Impact analysis of COVID-19 on the meningitis imaging  market

CHAPTER 4:MENINGITIS IMAGING MARKET, BY TYPE

4.1.Overview
4.2.Magnetic Resonance Imaging (MRI)

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Computed Tomography (CT)

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

4.4.Positron Emission Tomography (PET)

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

CHAPTER 5:MENINGTIS IMAGING  MARKET, BY DISEASE TYPE

5.1.Overview
5.2.Bacterial Meningitis

5.2.1 Market size and forecast, by region
5.2.1.Market analysis, by country

5.3.Viral Meningitis

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.Fungal Meningitis

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

5.5.Others

5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country

CHAPTER 6:MENINGTIS IMAGING  MARKET, BY END USER

6.1.Overview
6.2.Hospitals & Clinics

6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country

6.3.Diagnostic Centers

6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country

CHAPTER 7:MENINGITIS IMAGING  MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America meningitis imaging  market, by product type
7.2.3.North America meningitis imaging  market, by disease type
7.2.4.North America meningitis imaging  market, by end user
7.2.5.Market size and forecast, by country

7.2.5.1.U.S.

7.2.5.1.1.U.S. meningitis imaging  market, by product type
7.2.5.1.2.U.S. meningitis imaging  market, by disease type
7.2.5.1.3.U.S. meningitis imaging  market, by end User

7.2.5.2.Canada

7.2.5.2.1.Canada meningitis imaging  market, by product type
7.2.5.2.2.Canada meningitis imaging  market, by disease type
7.2.5.2.3.Canada meningitis imaging  market, by end user

7.2.5.3.Mexico

7.2.5.3.1.Mexico meningitis imaging  market, by product type
7.2.5.3.2.Mexico meningitis imaging  market, by disease type
7.2.5.3.3.Mexico meningitis imaging  market, by end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe meningitis imaging  market, by product type
7.3.3.Europe meningitis imaging  market, by disease type
7.3.4.Europe meningitis imaging  market, by end user
7.3.5.Market size and forecast, by country

7.3.5.1.Germany

7.3.5.1.1.Germany meningitis imaging  market, by product type
7.3.5.1.2.Germany meningitis imaging  market, by disease type
7.3.5.1.3.Germany meningitis imaging  market, by end user

7.3.5.2.France

7.3.5.2.1.France meningitis imaging  market, by product type
7.3.5.2.2.France meningitis imaging  market, by disease type
7.3.5.2.3.France meningitis imaging  market, by end user

7.3.5.3.UK

7.3.5.3.1.UK meningitis imaging  market, by product type
7.3.5.3.2.UK meningitis imaging  market, by disease type
7.3.5.3.3.UK meningitis imaging  market, by end user

7.3.5.4.Italy

7.3.5.4.1.Italy meningitis imaging  market, by product type
7.3.5.4.2.Italy meningitis imaging  market, by disease type
7.3.5.4.3.Italy meningitis imaging  market, by end user

7.3.5.5.Spain

7.3.5.5.1.Spain meningitis imaging  market, by product type
7.3.5.5.2.Spain meningitis imaging  market, by disease type
7.3.5.5.3.Spain meningitis imaging  market, by end user

7.3.5.6.Rest of Europe

7.3.5.6.1.Rest of Europe meningitis imaging  market, by product type
7.3.5.6.2.Rest of Europe meningitis imaging  market, by disease type
7.3.5.6.3.Rest of Europe meningitis imaging  market, by end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific meningitis imaging  market, by product type
7.4.3.Asia-Pacific meningitis imaging  market, by disease type
7.4.4.Asia-Pacific meningitis imaging  market, by end user
7.4.5.Market size and forecast, by country

7.4.5.1.Japan

7.4.5.1.1.Japan meningitis imaging market, by product type
7.4.5.1.2.Japan meningitis imaging  market, by disease type
7.4.5.1.3.Japan meningitis imaging  market, by end user

7.4.5.2.China

7.4.5.2.1.China meningitis imaging  market, by product type
7.4.5.2.2.China meningitis imaging  market, by disease type
7.4.5.2.3.China meningitis imaging  market, by end user

7.4.5.3.Australia

7.4.5.3.1.Australia meningitis imaging  market, by product type
7.4.5.3.2.Australia meningitis imaging  market, by disease type
7.4.5.3.3.Australia meningitis imaging  market, by end user

7.4.5.4.India

7.4.5.4.1.India meningitis imaging  market, by product type
7.4.5.4.2.India meningitis imaging market, by disease type
7.4.5.4.3.India meningitis imaging  market, by end user

7.4.5.5.South Korea

7.4.5.5.1.South Korea meningitis imaging  market, by product type
7.4.5.5.2.South Korea meningitis imaging  market, by disease type
7.4.5.5.3.South Korea meningitis imaging  market, by end user

7.4.5.6.Rest of Asia-Pacific

7.4.5.6.1.Rest of Asia-Pacific meningitis imaging  market, by product type
7.4.5.6.2.Rest of Asia-Pacific meningitis imaging  market, by disease type
7.4.5.6.3.Rest of Asia-Pacific meningitis imaging  market, by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA meningitis imaging  market, by product type
7.5.3.LAMEA meningitis imaging  market, by disease type
7.5.4.LAMEA meningitis imaging  market, by end user
7.5.5.Market size and forecast, by country

7.5.5.1.Latin America

7.5.5.1.1.Latin America meningitis imaging  market, by product type
7.5.5.1.2.Latin America meningitis imaging  market, by disease type
7.5.5.1.3.Latin America meningitis imaging  market, by end user

7.5.5.2.Middle East & Africa

7.5.5.2.1.Middle East and Africa meningitis imaging  market, by product type
7.5.5.2.2.Middle East and Africa meningitis imaging  market, by disease type
7.5.5.2.3.Middle East and Africa meningitis imaging  market, by end user

CHAPTER 8:COMPANY PROFILES: MENINGITIS IMAGING MARKET

1.1ACCURAY INCORPORATED
1.2CANON MEDICAL SYSTEMS CORPORATION (CANON INC.)

8.1.1.

1.3FUJIFILM HOLDING CORPORATION
1.4GE HEALTHCARE
1.5KONINKLIJKE PHILIPS NV

1.4.6        Business performance

1.6NEUSOFT MEDICAL SYSTEMS CO. LTD.

8.1.2.1.6.4    Key strategic moves and developments

1.7POSITRON CORPORATION

8.1.3.1.7.1      Company overview
8.1.4.1.7.2      Company snapshot

8.1.5.

8.1.6.1.7.3    0perating business segments
8.1.7.1.7.4      Product portfolio

8.1.8.
8.1.9.
8.1.10.

1.8SAMSUNG ELECTRONICS CO.LTD

8.1.11.1.8.1       Company overview
8.1.12.1.8.2      Company snapshot

8.1.13.

8.1.14.1.8.3      Operating business segments
8.1.15.1.8.4      Product portfolio
8.1.16.1.8.5        Business performance

1.9SHIMADZU CORPORATION

1.9.1     Company overview
1.9.2      Company snapshot
1.9.3    Operating business segments

1.10SEIMENS AG

LIST OF TABLES

TABLE 01.MAGNETIC RESONANCE IMAGING FOR MENINGITIS IMAGING MARKET, BY REGION, 2020-2030 ($THOUSAND)
TABLE 02.COMPUTER TOMOGRAPHY FOR MENINGITIS IMAGING MARKET , BY REGION, 2020-2030 ($THOUSAND)
TABLE 03.POSITRON EMISSION TOMOGRAPHY MENINGITIS IMAGING MARKET, BY REGION, 2020-2030 ($THOUSAND)
TABLE 04.MENINGTIS IMAGING  MARKET FOR BACTERIAL MENINGITIS , BY REGION, 2020-2030 ($THOUSAND)
TABLE 05.MENIGITIS IMAGING MARKET FOR VIRAL MENINGITIS, BY REGION, 2020-2030 ($THOUSAND)
TABLE 06.MENINGTIS IMAGING  MARKET FOR FUNGAL MENINGITIS, BY REGION, 2020-2030 ($MILLION)
TABLE 07.MENINGTIS IMAGING MARKET FOR OTHERS, BY REGION, 2020-2030 ($THOUSAND)
TABLE 08.HOSPITALS & CLINICS MENINGITIS IMAGING  MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 09.DIAGNOSTIC CENTERS MENINGTIS IMAGING  MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 10.GLOBAL MENINGTIS IMAGING  MARKET, BY REGION, 2020-2030 ($THOUSAND)
TABLE 11.NORTH AMERICA MENINGITIS IMAGING  MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
TABLE 12.NORTH AMERICA MENINGITIS IMAGING  MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
TABLE 13.NORTH AMERICA MENINGITIS IMAGING  MARKET, BY END USER, 2020-2030 ($THOUSAND)
TABLE 14.NORTH AMERICA MENINGITIS IMAGING  MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 15.U.S. MENINGITIS IMAGING  MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
TABLE 16.U.S. MENINGITIS IMAGING  MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
TABLE 17.U.S. MENINGITIS IMAGING  MARKET, BY END USER, 2020-2030 ($THOUSAND)
TABLE 18.CANADA MENINGITIS IMAGING  MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
TABLE 19.CANADA MENINGITIS IMAGING  MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
TABLE 20.CANADA MENINGITIS IMAGING  MARKET, BY END USER, 2020-2030 ($THOUSAND)
TABLE 21.MEXICO MENINGITIS IMAGING  MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
TABLE 22.MEXICO MENINGITIS IMAGING  MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
TABLE 23.MEXICO MENINGITIS IMAGING  MARKET, BY END USER, 2020-2030 ($THOUSAND)
TABLE 24.EUROPE MENINGITIS IMAGING  MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
TABLE 25.EUROPE MENINGITIS IMAGING  MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
TABLE 26.EUROPE MENINGITIS IMAGING  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 27.EUROPE MENINGITIS IMAGING  MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 28.GERMANY MENINGITIS IMAGING  MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
TABLE 29.GERMANY MENINGITIS IMAGING  MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
TABLE 30.GERMANY MENINGITIS IMAGING  MARKET, BY END USER, 2020-2030 ($THOUSAND)
TABLE 31.FRANCE MENINGITIS IMAGING  MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
TABLE 32.FRANCE MENINGITIS IMAGING  MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
TABLE 33.FRANCE MENINGITIS IMAGING  MARKET, BY END USER, 2020-2030 ($THOUSAND)
TABLE 34.UK MENINGITIS IMAGING  MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
TABLE 35.UK MENINGITIS IMAGING  MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
TABLE 36.UK MENINGITIS IMAGING  MARKET, BY END USER, 2020-2030 ($THOUSAND)
TABLE 37.ITALY MENINGITIS IMAGING  MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 38.ITALY MENINGITIS IMAGING  MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
TABLE 39.ITALY MENINGITIS IMAGING  MARKET, BY END USER, 2020-2030 ($THOUSAND)
TABLE 40.SPAIN MENINGITIS IMAGING  MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
TABLE 41.SPAIN MENINGITIS IMAGING  MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
TABLE 42.SPAIN MENINGITIS IMAGING  MARKET, BY END USER, 2020-2030 ($THOUSAND)
TABLE 43.REST OF EUROPE MENINGITIS IMAGING  MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
TABLE 44.REST OF EUROPE MENINGITIS IMAGING  MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
TABLE 45.REST OF EUROPE MENINGITIS IMAGING  MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 46.ASIA-PACIFIC MENINGITIS IMAGING  MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
TABLE 47.ASIA-PACIFIC MENINGITIS IMAGING  MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
TABLE 48.ASIA-PACIFIC MENINGITIS IMAGING  MARKET, BY END USER, 2020-2030 ($THOUSAND)
TABLE 49.ASIA-PACIFIC MENINGITIS IMAGING  MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 50.JAPAN MENINGITIS IMAGING  MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
TABLE 51.JAPAN MENINGITIS IMAGING  MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
TABLE 52.JAPAN MENINGITIS IMAGING  MARKET, BY END USER, 2020-2030 ($THOUSAND)
TABLE 53.CHINA MENINGITIS IMAGING  MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
TABLE 54.CHINA MENINGITIS IMAGING  MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
TABLE 55.CHINA MENINGITIS IMAGING  MARKET, BY END USER, 2020-2030 ($THOUSAND)
TABLE 56.AUSTRALIA MENINGITIS IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
TABLE 57.AUSTRALIA MENINGITIS IMAGING  MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
TABLE 58.AUSTRALIA MENINGITIS IMAGING  MARKET, BY END USER, 2020-2030 ($THOUSAND)
TABLE 59.INDIA MENINGITIS IMAGING  MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
TABLE 60.INDIA MENINGITIS IMAGING  MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
TABLE 61.INDIA MENINGITIS IMAGING  MARKET, BY END USER, 2020-2030 ($THOUSAND)
TABLE 62.SOUTH KOREA MENINGITIS IMAGING  MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
TABLE 63.SOUTH KOREA MENINGITIS IMAGING  MARKET, BY DISEASE TYPE2020-2030 ($THOUSAND)
TABLE 64.SOUTH KOREA MENINGITIS IMAGING  MARKET, BY END USER, 2020-2030 ($THOUSAND)
TABLE 65.REST OF ASIA-PACIFIC MENINGITIS IMAGING  MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
TABLE 66.REST OF ASIA-PACIFIC MENINGITIS IMAGING  MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
TABLE 67.REST OF ASIA-PACIFIC MENINGITIS IMAGING  MARKET, BY END USER, 2020-2030 ($THOUSAND)
TABLE 68.LAMEA MENINGITIS IMAGING  MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
TABLE 69.LAMEA MENINGITIS IMAGING  MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
TABLE 70.LAMEA MENINGITIS IMAGING  MARKET, BY END USER, 2020-2030 ($THOUSAND)
TABLE 71.LAMEA MENINGITIS IMAGING  MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 72.LATIN AMERICA MENINGITIS IMAGING  MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
TABLE 73.LATIN AMERICA MENINGITIS IMAGING  MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
TABLE 74.LATIN AMERICA MENINGITIS IMAGING  MARKET, BY END USER, 2020-2030 ($THOUSAND)
TABLE 75.MIDDLE EAST AND AFRICA MENINGITIS IMAGING  MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
TABLE 76.MIDDLE EAST AND AFRICA MENINGITIS IMAGING MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
TABLE 77.SAUDI ARABIA MENINGITIS IMAGING  MARKET, BY END USER, 2020-2030 ($THOUSAND)
TABLE 78.ACCURAY: COMPANY SNAPSHOT
TABLE 79.ACCURAY: PRODUCT PORTFOLIO
TABLE 80.CANON: COMPANY SNAPSHOT
TABLE 81.CANON: PRODUCT PORTFOLIO
TABLE 82.FUJIFILM:COMPANY SNAPSHOT
TABLE 83.FUJIFILM: OPERATING SEGMENTS
TABLE 84.FUJIFILM: PRODUCT PORTFOLIO
TABLE 85.GE:COMPANY SNAPSHOT
GE: OPERATING SEGMENTS
TABLE 86.GE: PRODUCT PORTFOLIO
TABLE 87.PHILIPS: COMPANY SNAPSHOT
TABLE 88.PHILIPS: OPERATING SEGMENTS
TABLE 89.PHILIPS: PRODUCT PORTFOLIO
TABLE 90.NEUSOFT : COMPANY SNAPSHOT
TABLE 91.NEUSOFT: PRODUCT PORTFOLIO
TABLE 92.POSITRON: COMPANY SNAPSHOT
TABLE 93.POSITRON: PRODUCT PORTFOLIO
TABLE 94.SAMSUNG: COMPANY SNAPSHOT
TABLE 95.SAMSUNG: PRODUCT PORTFOLIO
TABLE 96.SHIMADZU: COMPANY SNAPSHOT
TABLE 97.SHIMADZU: OPERATING SEGMENTS
TABLE 98.SHIMADZU: PRODUCT PORTFOLIO
TABLE 99.SIEMENS: COMPANY SNAPSHOT
TABLE 100.SIEMENS : OPERATING SEGMENTS
TABLE 101.SIEMENS: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.MENINGITIS IMAGING  MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE COMPETITIVE  RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF MENINGITIS IMAGING MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY COUNTRY, 2020-2030 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF MENINGITIS IMAGING MARKET FOR COMPUTER TOMOGRAPHY, BY COUNTRY, 2020-2030 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF MENINGTIS IMAGING MARKET FOR POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2020-2030 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF MENINGITIS IMAGING MARKET FOR BACTERIAL MENINGITIS, BY COUNTRY, 2020-2030 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF MENINGTIS IMAGING MARKET FOR VIRAL MENINGITIS, BY COUNTRY, 2020-2030 (%)
FIGURE 18.COMPARATIVE ANALYSIS OF MENINGTIS IMAGING MARKET FOR FUNGAL MENINGITIS, BY COUNTRY, 2020-2030 (%)
FIGURE 19.COMPARATIVE ANALYSIS OF MENINGTIS IMAGING MARKET FOR OTHERS, BY COUNTRY, 2020-2030 (%)
FIGURE 20.COMPARATIVE ANALYSIS OF MENINGITIS IMAGING MARKET FOR HOSPITALS, BY COUNTRY, 2020-2030 (%)
FIGURE 21.COMPARATIVE ANALYSIS OF MENINGITIS IMAGING MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2020-2030 (%)
FIGURE 22.ACCURAY: NET SALES, 2018-2020 ($MILLION)
FIGURE 23.ACCURAY: REVENUE SHARE BY REGION, 2020  (%)
FIGURE 24.CANON: NET SALES, 2018-2020 ($MILLION)
FIGURE 25.CANON: REVENUE SHARE BY SEGMENT,2020 (%)
FIGURE 26.CANON: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 27.FUJIFILM: NET SALES, 2018-2020 ($MILLION)
FIGURE 28.FUJIFILM: REVENUE SHARE BY SEGMENT,2020 (%)
FIGURE 29.FUJIFILM: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 30.GE: NET SALES, 2018-2020 ($MILLION)
FIGURE 31.GE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 32.GE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 33.PHILIPS: NET SALES, 2018-2020 ($MILLION)
FIGURE 34.PHILIPS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 35.PHILIPS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 36.SAMSUNG: NET SALES, 2018-2020 ($MILLION)
FIGURE 37.SAMSUNG: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 38.SHIMADZU: NET SALES, 2018-2020 ($MILLION)
FIGURE 39.SHIMADZU: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 40.SHIMADZU: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 41.SIEMENS: NET SALES, 2018-2020 ($MILLION)
FIGURE 42.SIEMENS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 43.SIEMENS: REVENUE SHARE BY REGION, 2020 (%)

 
 

Increasing prevalence of meningitis disease, increase in incidences of bacterial infection, shift of medical care toward image-guided interventions, and technological advancements are all attributed for growth of the meningitis imaging market. Greater consumer awareness and demand for preventive diagnostic screening, escalating demand for healthcare services from overall population and new technical advancements are predicted to broaden clinical applications of diagnostic imaging technology and increase the number of scans conducted.

In addition, increased participation of governments to control the outbreaks of meningitis is expected to drive the market. Furthermore, emphasis on less invasive procedures for diagnosis, as well as growing popularity of automated workflow in emergency clinical settings, contributes toward growth of the market.

The market gains interest of healthcare companies to launch a various types of imaging systems, owing to focus on preventive diagnosis and early detection of diseases. Highly advanced CT scanners, and MRI scan providing 3D images virtually in any patient, for those who have brain and spinal cord disorders, which are more complex than other health conditions. This leads to increase in utilization of imaging tools to identify meningitis infection, thus is a great opportunity for further propelling growth of the market.

North America is expected to witness highest growth, in terms of revenue, owing to rise in meningitis in newborn babies and children under the age of 5 years, presence of key players, and advancements in healthcare investments. Asia-Pacific was the second largest contributor to the market in 2020, and is expected to register the fastest CAGR during the forecast period, owing to increase in incidences of chronic diseases, unmet needs for advanced diagnostic systems, and increasing awareness for preventive diagnosis in the healthcare sector. However, high cost of implementation, maintenance, and stringent government policies restrain the market growth.

 

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of meningitis imaging market is $164.70 thousand in 2020.

A. The forecast period for meningitis imaging market is 2021 to 2030

A. The market value of meningitis imaging market in 2021 is $243.72 thousand.

A. The base year is 2020 in meningitis imaging market.

A. Top companies such as Accuray Incorporated, Canon Medical Systems Corporation, Fujifim Holdings Corporation, GE Healthcare, Koninklijke Philips N.V, Neusoft Medical Systems, Positron Corporation, Samsung Electronics Co.Ltd., Shimadzu Corporation, and Siemens AG held a high market position in 2020.

A. Computer tomography segment dominated the global market in 2020, and expected to continue this trend throughout the forecast period due to the technological advancements and new product launch and thus is expected to drive the segment.

A. Increase in demand for new technologies in meningitis imaging such as cone beam CT, photon-counting CT, and also technological advancements in magnetic resonance imaging (MRI) systems for meningitis imaging and advanced infrastructure for research & development and investments in healthcare is anticipated to drive the market in the forecast period.

A. North America is projected to account for a major share of the global meningitis imaging market during the forecast period. U.S. dominated the North America rise in investments for new meningitis imaging system launch in the R & D sector due to presence of key players across the country.

A. Meningitis imaging is diagnostic imaging procedure used to diagnose meningitis infection in patients.

A. Meningitis imaging market products are used for diagnosis of meningitis using MRI devices, CT scanners and PET scanners which are able to examine the meninges of the brain and spinal cord.

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Meningitis Imaging Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers